JB CHEMICALS & PHARMACEUTICALS
Quarterly Results Analysis [Mar2024]
JB CHEMICALS & PHARMACEUTICALS Quarterly Results
Consolidated | Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹862 Cr | ₹845 Cr | ₹882 Cr | ₹896 Cr | ₹762 Cr | ₹793 Cr | ₹809 Cr | ₹785 Cr |
Expenses | ₹664 Cr | ₹621 Cr | ₹638 Cr | ₹664 Cr | ₹599 Cr | ₹618 Cr | ₹625 Cr | ₹612 Cr |
Operating Income | ₹198 Cr | ₹223 Cr | ₹244 Cr | ₹232 Cr | ₹164 Cr | ₹175 Cr | ₹185 Cr | ₹173 Cr |
Other Income | ₹17 Cr | ₹7 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹9 Cr | ₹12 Cr | ₹10 Cr | ₹12 Cr | ₹14 Cr | ₹8 Cr | ₹8 Cr | ₹6 Cr |
Depreciation | ₹41 Cr | ₹34 Cr | ₹32 Cr | ₹31 Cr | ₹32 Cr | ₹28 Cr | ₹28 Cr | ₹26 Cr |
Profit Before Tax | ₹165 Cr | ₹184 Cr | ₹209 Cr | ₹194 Cr | ₹122 Cr | ₹141 Cr | ₹150 Cr | ₹142 Cr |
Profit After Tax | ₹126 Cr | ₹134 Cr | ₹151 Cr | ₹142 Cr | ₹88 Cr | ₹106 Cr | ₹111 Cr | ₹105 Cr |
EPS | ₹8.13 | ₹8.62 | ₹9.72 | ₹9.19 | ₹5.66 | ₹6.86 | ₹7.18 | ₹6.79 |
Industry Peers & Returns | 1W | 1M | 1Y |
JB CHEMICALS & PHARMACEUTICALS | -9.4% | -8.6% | 72.1% |
SUN PHARMACEUTICAL INDUSTRIES | -2.9% | 0% | 59.6% |
CIPLA | 5.8% | 6.2% | 60.9% |
DR REDDYS LABORATORIES | 0.9% | -1.5% | 32.2% |
ZYDUS LIFESCIENCES | -2.6% | 15.3% | 114.4% |
DIVIS LABORATORIES | 5% | 8% | 25.9% |
MANKIND PHARMA | -2.3% | -14% | 57.7% |
TORRENT PHARMACEUTICALS | -3.4% | -2.7% | 61.2% |
LUPIN | -2.8% | 2.1% | 110.5% |
JB CHEMICALS & PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 2.04 % |
Y-o-Y | 13.04 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹862 Cr | 2.04 | |
Dec2023 | ₹845 Cr | -4.22 | |
Sep2023 | ₹882 Cr | -1.61 | |
Jun2023 | ₹896 Cr | 17.56 | |
Mar2023 | ₹762 Cr | -3.83 | |
Dec2022 | ₹793 Cr | -2.07 | |
Sep2022 | ₹809 Cr | 3.14 | |
Jun2022 | ₹785 Cr | - |
JB CHEMICALS & PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -11.20 % |
Y-o-Y | 21.07 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹198 Cr | -11.20 | |
Dec2023 | ₹223 Cr | -8.38 | |
Sep2023 | ₹244 Cr | 4.92 | |
Jun2023 | ₹232 Cr | 41.84 | |
Mar2023 | ₹164 Cr | -6.37 | |
Dec2022 | ₹175 Cr | -5.31 | |
Sep2022 | ₹185 Cr | 6.84 | |
Jun2022 | ₹173 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -12.98 % |
Y-o-Y | 7.08 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 22.99% | -12.98 | |
Dec2023 | 26.42% | -4.34 | |
Sep2023 | 27.62% | 6.64 | |
Jun2023 | 25.9% | 20.63 | |
Mar2023 | 21.47% | -2.63 | |
Dec2022 | 22.05% | -3.29 | |
Sep2022 | 22.8% | 3.59 | |
Jun2022 | 22.01% | - |
JB CHEMICALS & PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -5.55 % |
Y-o-Y | 43.97 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹126 Cr | -5.55 | |
Dec2023 | ₹134 Cr | -11.30 | |
Sep2023 | ₹151 Cr | 5.81 | |
Jun2023 | ₹142 Cr | 62.41 | |
Mar2023 | ₹88 Cr | -17.41 | |
Dec2022 | ₹106 Cr | -4.48 | |
Sep2022 | ₹111 Cr | 5.59 | |
Jun2022 | ₹105 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -7.46 % |
Y-o-Y | 27.30 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 14.64 % | -7.46 | |
Dec2023 | 15.82 % | -7.38 | |
Sep2023 | 17.08 % | 7.56 | |
Jun2023 | 15.88 % | 38.09 | |
Mar2023 | 11.5 % | -14.05 | |
Dec2022 | 13.38 % | -2.48 | |
Sep2022 | 13.72 % | 2.39 | |
Jun2022 | 13.4 % | - |
JB CHEMICALS & PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -5.68 % |
Y-o-Y | 43.64 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹8.13 | -5.68 | |
Dec2023 | ₹8.62 | -11.32 | |
Sep2023 | ₹9.72 | 5.77 | |
Jun2023 | ₹9.19 | 62.37 | |
Mar2023 | ₹5.66 | -17.49 | |
Dec2022 | ₹6.86 | -4.46 | |
Sep2022 | ₹7.18 | 5.74 | |
Jun2022 | ₹6.79 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD